You are here: Industry Insights > colitis

News List

EC expands label of Janssen’s Stelara to include ulcerative colitis pharmaceutical-technology
September 10, 2019
Johnson & Johnson subsidiary Janssen has announced the European Commission (EC) has approved Stelara (ustekinumab) for patients with moderately to severely active ulcerative colitis (UC).
EC approves expanded use of ustekinumab for ulcerative colitis europeanpharmaceuticalreview
September 09, 2019
The biologic treatment ustekinumab has been granted an expanded use for ulcerative colitis within the EU.
Ulcerative Colitis Outcomes Similar for Smokers, Nonsmokers drugs
August 12, 2019
Smokers and nonsmokers with ulcerative colitis (UC) have similar outcomes, according to a study published online in Alimentary Pharmacology and Therapeutics.
FDA: Blood Clot, Death Risk Up With Higher Dose of Tofacitinib drugs
July 29, 2019
New warnings about an increased risk of thrombosis and of death among ulcerative colitis patients taking the 10 mg twice daily dose of the drug tofacitinib...
Precision editing of gut bacteria: Potential way to treat colitis worldpharmanews
January 05, 2018
UT Southwestern Medical Center researchers have used precision editing of the bacterial populations in the gut to prevent or reduce the severity of inflammation in a mouse model of colitis.
New study confirms effectiveness of BCM-95 to treat colitis, says Arjuna pharmaceutical-technology
April 27, 2017
New study confirms effectiveness of BCM-95 to treat colitis, says Arjuna - Pharmaceutical Technology